Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...

Canopy Growth Corporation’s CGC share price has surged by 22.22%, which has investors questioning if this is right time to sell.

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Canopy Growth (CGC) to C$4 from C$7 and keeps a Neutral rating ...

Canopy Growth (CGC) delivered earnings and revenue surprises of -58.33% and 12.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Tilray, Gibraltar Industries, Innovative Industrial Properties, Turning Point Brands, Canopy Growth, Indivior, and SNDL are the seven Cannabis stocks to watch today, according to MarketBeat’s stock ...

Tilray, Gibraltar Industries, Innovative Industrial Properties, Turning Point Brands, and Canopy Growth are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool.

Its stock has since plummeted to it’s current price of $2.91. Canopy Growth Corp has $226M cash left after a $5B injection seven years ago, indicating rapid cash burn. With $280M revenue ...